Latest in AIMS Psilocybin Right-To-Try Effort

Latest in AIMS Psilocybin Right-To-Try EffortWe have taken an additional step recently in our effort to secure psilocybin therapeutic use for two of our cancer patients under State and Federal Right to Try (RTT) laws. On Monday 3/8/21, on behalf of AIMS Institute and Dr. Aggarwal, lawyers filed a petition for review in U.S. Ninth Circuit Court of Appeals of the DEA’s written decision last month to deny our request for RTT access to psilocybin from a duly licensed producer.

Below is the press release that went out and links to some news stories that have appeared.

We are looking for leading organizations committed to protecting the rights of seriously ill patients to have immediate access to safe use of psychedelic-assisted therapy to file ‘friend of the court’ amicus briefs in the case. Please get in touch if your organization or one you know of is interested in lending their voice of support to help our patients receive therapeutic access to the eligible investigational drug psilocybin under right to try. We have a great opportunity here to help advance this very needed therapeutic modality in contemporary hospice and palliative care. Patients treated by palliative care and mental health specialists in Canada have already been able to avail fungal psilocybin-assisted therapy legally under Canadian government exemptions for the past 7 months, and it has been very beneficial in palliation of existential and other distress by all reports.

Press Release: NATION’S FIRST LEGAL CHALLENGE TO ALLOW PSILOCYBIN THERAPY IN END-OF-LIFE CARE UNDER “RIGHT-TO-TRY” LAWS MOVES FORWARD
https://goteamtbg.com/dying-patients-need-access-to-psilocybin-for-anxiety-and-depression-relief/

Oregon Public Broadcasting: Physicians ask DEA to rethink ban on psilocybin
https://www.opb.org/article/2021/03/09/physicians-ask-dea-to-rethink-ban-on-psilocybin/

Marijuana Moment: DEA Sued By Doctor Who Wants Permission To Give Psilocybin Mushrooms To Patients
https://www.marijuanamoment.net/dea-sued-by-therapists-who-want-permission-to-give-psilocybin-mushrooms-to-patients/

Clinician, Patients Take the Fight for Psilocybin To Court
https://www.psychiatrictimes.com/view/clinician-patients-take-fight-psilocybin-to-court

Why Dying Patients Are Suing for Access to Magic Mushrooms
https://today.westlaw.com/Document/Icf70e0e081e411eb835ee9025e2233da/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0

Seattle Doctor, Lawyer Speak Out on Landmark DEA Psilocybin Lawsuit
truffle.report/seattle-doctor-lawyer-speak-out-on-landmark-dea-psilocybin-lawsuit/

Seattle Doctor, Lawyer Speak Out on Landmark DEA Psilocybin Lawsuit
truffle.report/seattle-doctor-lawyer-speak-out-on-landmark-dea-psilocybin-lawsuit/

Suing the DEA for Access to Psilocybin
https://www.mushroomrevival.com/blogs/podcast/suing-the-dea-for-access-to-psilocybin?fbclid=IwAR1QLWYCMjISeWOdoHQVqlb1PaI1iA8NvsSgh7rut71VqZDQpAjU089fUBstruffle.report/seattle-doctor-lawyer-speak-out-on-landmark-dea-psilocybin-lawsuit/

 

Latest Blog Posts

Watch now: Psychedelics and Grief: When Containment Stops Working 

Watch now: Psychedelics and Grief: When Containment Stops Working 

Supporting women in the wild with science and wisdom about psychedelics. 134. Psychedelics and Grief: When Containment Stops Working Dr. Sunil Aggarwal joins April Pride to talk psilocybin, grief, and the difference between containing a loss and integrating it. April Pride Sep 29 Recently, it occurred to me that my relationship with trust needed tending. When I told a friend, she asked, “Why don’t you trust yourself?” I’ve been sitting with that question because it tracks and it confuses me at the same time. I’ve walked into divorce, entrepreneurship, and work in the Schedule I-adjacent world. Not the choices of ...

Read More
Breakthrough Therapeutics in Complex Illness

Breakthrough Therapeutics in Complex Illness

How Academy Members Are Integrating Psychedelics to Ease Distress Dr. Sunil Aggarwal is quoted in the feature story in the 2026 Fall Quarterly Newsletter from the American Academy of Hospice and Palliative Medicine. For patients facing serious illness, some of the deepest suffering cannot be measured on a numerical scale.  Some patients experience anxiety that does not respond to conventional treatment, as well as a deep sense of demoralization, isolation, and loss of meaning. Palliative and hospice care have long recognized treatment of this existential distress as central to whole-person care. Now, an emerging field of research is asking whether ...

Read More
Psychedelic science update & harm reduction training for naturopathic physicians

Psychedelic science update & harm reduction training for naturopathic physicians

8 CONTINUING EDUCATION (CE) HOURS FEBRUARY 1–4, 2027OPIHIHALE ETHNOBOTANICAL PRESERVEBig Island, Hawai‘i $2,850 INCLUDES Three nights lodging | All mealsGround transportation to and from Kona AirportCourse materials | Guided ethnobotanical tour AIMS Institute in collaboration with Opihihale Ethnobotanical Preserve WHY THIS COURSE? As interest in psychedelic therapies continues to grow, naturopathic physicians are increasingly asked about their safety, effectiveness, legal status, and appropriate clinical use. This immersive continuing education program provides an evidence-based review of current psychedelic science together with practical harm reduction strategies for clinicians whose patients are considering or using psychedelic medicines. Presented by the AIMS Institute in ...

Read More

Accessibility Tools

Increase TextIncrease Text
Decrease TextDecrease Text
GrayscaleGrayscale
Invert Colors
Readable FontReadable Font
Reset
Call Us Text Us